Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 6101 - 6125 of 8235 in total
Morinidazole is under investigation in clinical trial NCT03380793 (A Trial to Assess the Efficacy and Safety of Morinidazole in Patients With Appendicitis).
Investigational
Matched Description: … Morinidazole is under investigation in clinical trial NCT03380793 (A Trial to Assess the Efficacy and Safety of
Transfluthrin is under investigation in clinical trial NCT02394522 (Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Zambia (SR-M-ZM)).
Investigational
Matched Description: … Transfluthrin is under investigation in clinical trial NCT02394522 (Spatial Repellent Products for Control of
Voruciclib is under investigation in clinical trial NCT03547115 (A Phase 1 Study of Voruciclib in Subjects With B-Cell Malignancies or AML).
Investigational
Matched Description: … Voruciclib is under investigation in clinical trial NCT03547115 (A Phase 1 Study of Voruciclib in Subjects …
CNV-2197944 is under investigation in clinical trial NCT01893125 (Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Diabetic Peripheral Neuropathy).
Investigational
Matched Description: … CNV-2197944 is under investigation in clinical trial NCT01893125 (Efficacy and Safety of CNV2197944 Versus …
Batoclimab is under investigation in clinical trial NCT04428255 (A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP).
Investigational
Matched Description: … Batoclimab is under investigation in clinical trial NCT04428255 (A Clinical Study on the Efficacy and Safety of
ASTX660 is under investigation in clinical trial NCT02503423 (Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas).
Investigational
Matched Description: … ASTX660 is under investigation in clinical trial NCT02503423 (Phase 1-2 Study of ASTX660 in Subjects …
Geptanolimab is under investigation in clinical trial NCT03502629 (Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)).
Investigational
Matched Description: … Geptanolimab is under investigation in clinical trial NCT03502629 (Clinical Trial in Chinese Patients of
Vecabrutinib is under investigation in clinical trial NCT03037645 (Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers).
Investigational
Matched Description: … Vecabrutinib is under investigation in clinical trial NCT03037645 (Safety, PK, PD, and Antitumor Activity of
Bucelipase alfa is under investigation in clinical trial NCT00743483 (Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency).
Investigational
Matched Description: … Bucelipase alfa is under investigation in clinical trial NCT00743483 (Efficacy of Bucelipase Alfa (BSSL …
Alrizomadlin is a novel MDM2 inhibitor that blocks the interaction of MDM2 and p53. It is being investigated in cancers.[A257281,A257286]
Investigational
Matched Description: … Alrizomadlin is a novel MDM2 inhibitor that blocks the interaction of MDM2 and p53. …
MB-107 consists of mobilized peripheral blood-derived autologous CD34+ hematopoietic stem cells that are genetically modified to express the IL2RG gene.
Investigational
Matched Description: … MB-107 consists of mobilized peripheral blood-derived autologous CD34+ hematopoietic stem cells that …
Methylcantharidimide is under investigation in clinical trial NCT03996681 (TACE Combined With Methylcantharidimide Tablets in the Treatment of Large and Unresectable Hepatocellular Carcinoma).
Investigational
Matched Description: … investigation in clinical trial NCT03996681 (TACE Combined With Methylcantharidimide Tablets in the Treatment of
Arterolane is under investigation in clinical trial NCT03452475 (Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+mefloquine Versus Artemether-lumefantrine in Kenyan Children).
Investigational
Matched Description: … Arterolane is under investigation in clinical trial NCT03452475 (Comparison of Arterolane-piperaquine …
Quisqualic acid is an agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium mobilization from intracellular stores. The compound is obtained from the seeds and fruit of Quisqualis chinensis.
Experimental
Matched Description: … The compound is obtained from the seeds and fruit of _Quisqualis chinensis_. ... Quisqualic acid is an agonist at two subsets of excitatory amino acid receptors, ionotropic receptors …
PEG-uricase, a polyethylene glycol ("PEG") conjugate of recombinant porcine uricase (urate oxidase), which breaks down the uric acid deposits is being studied in Phase III clinical trials for the treatment of severe, treatment-refractory gout in the United States in 2006.
Investigational
Matched Description: … PEG-uricase, a polyethylene glycol ("PEG") conjugate of recombinant porcine uricase (urate oxidase), ... breaks down the uric acid deposits is being studied in Phase III clinical trials for the treatment of
Limonene is common in cosmetic products. As the main odor constituent of citrus (plant family Rutaceae), D-limonene is used in food manufacturing and some medicines, e.g. as a flavoring to mask the bitter taste of alkaloids, and as a fragrant in perfumery.
Investigational
Matched Description: … As the main odor constituent of citrus (plant family Rutaceae), D-limonene is used in food manufacturing ... and some medicines, e.g. as a flavoring to mask the bitter taste of alkaloids, and as a fragrant in …
Polycarbophil calcium is a synthetic polymer manufactured from the cross-linking of polyacrylic acid with divinyl glycol and a calcium counter-ion. Polycarbophil calcium is a stool stabilizer used to treat constipation. This drug may also be used to help relieve the symptoms of irritable bowel syndrome or diarrhea. Less gas and...
Experimental
Matched Description: … Polycarbophil calcium is a synthetic polymer manufactured from the cross-linking of polyacrylic acid ... This drug may also be used to help relieve the symptoms of irritable bowel syndrome or diarrhea. ... possesses exceptionally high water-binding capacity. is not absorbed, does not interfere with the activity of
Willardiine is a compound isolated from seeds of Acacia willariana.
Experimental
Matched Description: … Willardiine is a compound isolated from seeds of _Acacia willariana_. …
Thenoyltrifluoroacetone is a chelating agent and inhibitor of cellular respiration.
Experimental
Matched Description: … Thenoyltrifluoroacetone is a chelating agent and inhibitor of cellular respiration. …
PH-797804 has been investigated for the treatment of Osteoarthritis.
Investigational
Matched Description: … PH-797804 has been investigated for the treatment of Osteoarthritis. …
Bapineuzumab has been investigated for the treatment of Alzheimer's Disease.
Investigational
Matched Description: … Bapineuzumab has been investigated for the treatment of Alzheimer's Disease. …
Orteronel has been investigated for the treatment of Prostate Cancer.
Investigational
Matched Description: … Orteronel has been investigated for the treatment of Prostate Cancer. …
Piclozotan has been investigated for the treatment of Parkinson's Disease.
Investigational
Matched Description: … Piclozotan has been investigated for the treatment of Parkinson's Disease. …
Fanapanel has been investigated for the treatment of Visual Acuity.
Investigational
Matched Description: … Fanapanel has been investigated for the treatment of Visual Acuity. …
Cannabinol (CBN) is a physiologically inactive constituent of Cannabis sativa.
Experimental
Investigational
Matched Description: … Cannabinol (CBN) is a physiologically inactive constituent of Cannabis sativa. …
Displaying drugs 6101 - 6125 of 8235 in total